|
85
|
306
|
7vh8A |
Crystal structure of sars-cov-2 main protease in complex with protease inhibitor pf-07321332 |
|
82
|
303
|
7d3cA |
The newly emerged sars-like coronavirus hcov-emc also has an "achilles' heel": current effective inhibitor targeting a 3c-like protease |
|
86
|
306
|
7si9A |
Room temperature x-ray structure of sars-cov-2 main protease (mpro) in complex with pf-07321332 |
|
78
|
298
|
7eo8A |
Crystal structure of sars coronavirus main protease in complex with an inhibitor shikonin |
|
84
|
299
|
7eo7A |
Crystal structure of hcov-nl63 3c-like protease in complex with an inhibitor shikonin |
|
80
|
306
|
7p51A |
Crystal structure of the sars-cov-2 main protease complexed with fragment f01 |
|
87
|
306
|
7m2pA |
Structure of the sars-cov-2 3cl protease in complex with inhibitor 18 |
|
89
|
306
|
7lmiAAA |
Sars-cov-1 3clpro in complex with n-(4-(1h-pyrazol-4-yl)phenyl)-2-(1h-benzo[d][1,2,3]triazol-1-yl)-n-(thiophen-3-ylmethyl)acetamide |
|
93
|
306
|
7lmjAAA |
Sars-cov-1 3clpro in complex with 2-(1h-benzo[d][1,2,3]triazol-1-yl)-n-(3-chlorobenzyl)-n-(4-(2-oxo-1,2-dihydropyridin-3-yl)phenyl)acetamide |
|
81
|
305
|
7lmfA |
Sars-cov-2 3clpro in complex with 2-(benzotriazol-1-yl)-n-[4-(1h-imidazol-4-yl)phenyl]-n-(3-thienylmethyl)acetamide |
|
90
|
306
|
7lmgAAA |
Sars-cov-1 3clpro in complex with n-(4-(1h-imidazol-4-yl)phenyl)-2-(1h-benzo[d][1,2,3]triazol-1-yl)-n-(thiophen-3-ylmethyl)acetamide |
|
88
|
306
|
7lmhAAA |
Sars-cov-1 3clpro in complex with 2-(1h-benzo[d][1,2,3]triazol-1-yl)-n-(4-(pyridin-3-yl)phenyl)-n-(thiophen-3-ylmethyl)acetamide |
|
79
|
305
|
7l8iA |
Sars-cov-2 main protease (mpro) in complex with rupintrivir (p21) |
|
76
|
305
|
7l8jA |
Sars-cov-2 main protease (mpro) in complex with rupintrivir (p21212) |
|
87
|
306
|
7jp0A |
Crystal structure of mpro with inhibitor r1 |
|
90
|
304
|
7lmeA |
Sars-cov-2 3clpro in complex with n-[4-[[2-(benzotriazol-1-yl)acetyl]-(3-thienylmethyl)amino]phenyl]cyclopropanecarboxamide |
|
92
|
302
|
7lmdA |
Sars-cov-2 3clpro in complex with 2-(benzotriazol-1-yl)-n-[4-(1h-pyrazol-4-yl)phenyl]-n-(3-thienylmethyl)acetamide |
|
85
|
299
|
7e6nA |
Crystal structure of hcov-nl63 3c-like protease,ph5.2 |
|
86
|
299
|
7e6lA |
Crystal structure of hcov-nl63 3c-like protease,ph5.0 |
|
85
|
299
|
7e6rA |
Crystal structure of hcov-nl63 3c-like protease,ph5.6 |
|
86
|
299
|
7e6mA |
Crystal structure of human coronavirus nl63 3c-like protease |
|
79
|
298
|
7dqzA |
Crystal structure of sars 3c-like protease in apo form |
|
84
|
299
|
7d64A |
The crystal structure of sars-cov-2 3clpro with zinc |
|
87
|
306
|
7s3sA |
Room temperature x-ray structure of sars-cov-2 main protease in complex with compound z1530724813 |
|
88
|
306
|
7s3kA |
Room temperature x-ray structure of sars-cov-2 main protease in complex with compound z1530718726 |
|
79
|
305
|
7rn1A |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with inhibitor jun9-62-2r |
|
85
|
302
|
7rn0A |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with inhibitor jun9-57-3r |
|
89
|
306
|
7s4bA |
Room temperature x-ray structure of sars-cov-2 main protease in complex with compound z1530724963 |
|
80
|
305
|
7rbzA |
X-ray structure of sars-cov-2 main protease covalently modified by compound grl-017-20 |
|
82
|
306
|
7rc1A |
X-ray structure of sars-cov main protease covalently modified by compound grl-0686 |
|
93
|
305
|
7rc0A |
X-ray structure of sars-cov-2 main protease covalently modified by compound grl-091-20 |
|
74
|
306
|
7r7hA |
Peptidomimetic nitrile warheads as sars-cov-2 3cl protease inhibitors |
|
88
|
304
|
7p35AAA |
Structure of the sars-cov-2 3cl protease in complex with rupintrivir |
|
82
|
301
|
7n44A |
Crystal structure of the sars-cov-2 (2019-ncov) main protease in complex with 5-(3-{3-chloro-5-[(5-methyl-1,3-thiazol-4-yl)methoxy]phenyl}-2-oxo-2h-[1,3'-bipyridin]-5-yl)pyrimidine-2,4(1h,3h)-dione (compound 13) |
|
77
|
303
|
7mbiA |
Structure of sars-cov2 3cl protease covalently bound to peptidomimetic inhibitor |
|
86
|
301
|
7fayA |
Crystal structure of sars-cov-2 main protease in complex with (r)-1a |
|
84
|
301
|
7fazA |
Crystal structure of the sars-cov-2 main protease in complex with y180 |
|
89
|
301
|
7nw2A |
Crystal structure of sars-cov-2 main protease in complex with lon-wei-adc59df6-47 |
|
88
|
300
|
7einA |
Sars-cov-2 main proteinase complex with microbial metabolite leupeptin |
|
83
|
306
|
7lctA |
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability |
|
81
|
306
|
7lcoA |
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability |
|
83
|
306
|
7ldlA |
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability |
|
22
|
75
|
7mc9B |
X-ray structure of pedv papain-like protease 2 bound to ub-pa |
|
61
|
235
|
7mc9A |
X-ray structure of pedv papain-like protease 2 bound to ub-pa |
|
80
|
306
|
7lcsA |
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability |
|
86
|
299
|
7k0eA |
1.90 a resolution structure of sars-cov-2 3cl protease in complex with deuterated gc376 |
|
86
|
301
|
7m8mA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 11 |
|
82
|
301
|
7m8zA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 29 |
|
85
|
302
|
7m8xA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 6 |
|
85
|
305
|
7m91A |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 25 |
